Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

SB 109889.ª Legislatura (2025)

Qué cambió entre versiones

2 párrafos cambiaron+3 palabras agregadas−1 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

By: Blanco, Parkeret al.

S.B. No. 1098

(Hull)

A BILL TO BE ENTITLED

15 párrafos sin cambios

AN ACT

relating to the disclosure by a pharmacy to a patient of certain

price information for a drug or biological product.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Section 562.003, Occupations Code, is amended to

read as follows:

Sec. 562.003. DISCLOSURE OF PRICE; PATIENT'S OPTION. (a) A

pharmacy shall disclose the lowest cost cash price at that pharmacy

for the drug or biological product prescribed to the patient.

(b) If the price of a drug or biological product to a patient

is lower than the amount of the patient's copayment under the

patient's prescription drug insurance plan, the pharmacist shall

offer the patient the option of paying for the drug or biological

product at the lower price instead of paying the amount of the

copayment.

SECTION 2. This Act takes effect September 1, 2025.

Volver al texto completo